Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03956082 · ClinicalTrials.gov registry record · NA
Ultravision™ System to Facilitate Low Impact Laparoscopic Surgery for Endometriosis
A NA study, sponsored by Mercy Research.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03956082: Completed NA study, sponsored by Mercy Research.
NCT03956082 is a NA study that has completed, run by Mercy Research. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03956082, a NA study, has completed, sponsored by Mercy Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a prospective single arm study. The study will enroll 20 patients. Comparisons to prior clinical trials and published literature will be made to assess the relative significance of the study results.The study will enroll patients indicated for laparoscopic surgery to treat endometriosis. Patients must meet all inclusion/exclusion criteria. There are five main study objectives: 1. Demonstrate the feasibility of undertaking low impact laparoscopic surgery for endometriosis when using the Ultravision™ System. 2. Assess the impact of Ultravision on visual field clarity. 3. Determine the ability to complete the procedure while maintaining an abdominal pressure of \< 10mmHg. 4. Quantify the consumption of CO2. 5. Collect data on additional clinical outcomes associated with the use of Ultravision and low impact surgery (i.e. end tidal CO2 levels (EtCO2), adverse events, cosmesis outcome, postoperative pain levels and pain medications).
Primary Outcome
The ability to complete the procedure without increasing pneumoperitoneum due to visualization. Any increase beyond 10mm Hg and the reason for change will be recorded.
Interventions
- DEVICE Ultravision™ Visual Field Clearing System
- DEVICE Ultravision Ionwand™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-08-07 |
| Est. Completion | 2021-04-14 |
| Phase | NA |
What the finished NCT03956082 record still lists
NCT03956082 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Ultravision™ Visual Field Clearing System is the first listed.
NCT03956082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03956082 about?
NCT03956082 is a clinical study titled "Ultravision™ System to Facilitate Low Impact Laparoscopic Surgery for Endometriosis". This is a prospective single arm study. The study will enroll 20 patients. Comparisons to prior clinical trials and published literature will be made to assess the relative significance of the study results.The study will enroll patients indicated for laparoscopic surgery to treat endometriosis. Pat...
What is the current status of trial NCT03956082?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-08-07. Estimated completion is 2021-04-14.
What interventions are being tested in trial NCT03956082?
The interventions under investigation include: Ultravision™ Visual Field Clearing System (DEVICE), Ultravision Ionwand™ (DEVICE).
Who is sponsoring clinical trial NCT03956082?
This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03956082's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI